Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review - PubMed (original) (raw)
Review
. 2018 Mar;233(3):2091-2103.
doi: 10.1002/jcp.25911. Epub 2017 May 3.
Affiliations
- PMID: 28294322
- DOI: 10.1002/jcp.25911
Review
Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review
Mahboube Ganji-Arjenaki et al. J Cell Physiol. 2018 Mar.
Abstract
Altered gut bacteria and bacterial metabolic pathways are two important factors in initiation and progression of inflammatory bowel disease (IBD). However, efficacy of probiotics in remission of patients with IBD has not been characterized. This study was performed on the studies that specifically assessed the efficacy of probiotics in attaining clinical response on patients with various types of IBD. The efficacy of variant species of probiotics in different conditions and the influence of study quality in outcomes of randomized controlled trials (RCTs) were also assessed. The RCTs were collected by searching in MEDLINE Web of Science and Google scholar. Then all studies were abstracted in abstraction form and the outcomes were analyzed with fixed-effect and mixed-effect models for assessment of efficacy of variant species of probiotics in subgroups of IBDs. Analysis of 9 trials showed that probiotics had not significant effect on Crohn's disease (CD) (p = 0.07) but analysis of 3 trials in children with IBD revealed a significant advantage (p < 0.01). Analysis of 18 trials revealed that probiotics in patients with Ulcerative colitis (UC) in different conditions have significant effects (p = 0.007). VSL#3 probiotics in patients with UC had significant effect (p < 0.01). Combination of Lactobacillus probiotic, prebiotics had significant effect (p = 0.03) only in patients with UC. Combination of Saccharomyces boulardii, Lactobacillus, and VSL#3 probiotics in CD had also a trend for efficiency (p = 0.057). In children with IBD, the combination of Lactobacillus with VSL#3 probiotics had significant effect (p < 0.01). Probiotics are beneficial in IBD, especially the combination ones in UC.
Keywords: Crohn's disease; IBD; probiotics; ulcerative colitis.
© 2017 Wiley Periodicals, Inc.
Similar articles
- Probiotics and prebiotics in Crohn's disease therapies.
Lichtenstein L, Avni-Biron I, Ben-Bassat O. Lichtenstein L, et al. Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):81-8. doi: 10.1016/j.bpg.2016.02.002. Epub 2016 Feb 9. Best Pract Res Clin Gastroenterol. 2016. PMID: 27048899 Review. - Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Naseer M, Poola S, Ali S, Samiullah S, Tahan V. Naseer M, et al. Curr Clin Pharmacol. 2020;15(3):216-233. doi: 10.2174/1574884715666200312100237. Curr Clin Pharmacol. 2020. PMID: 32164516 Review. - Review of Saccharomyces boulardii as a treatment option in IBD.
Sivananthan K, Petersen AM. Sivananthan K, et al. Immunopharmacol Immunotoxicol. 2018 Dec;40(6):465-475. doi: 10.1080/08923973.2018.1469143. Epub 2018 May 17. Immunopharmacol Immunotoxicol. 2018. PMID: 29771163 Review. - Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
Derwa Y, Gracie DJ, Hamlin PJ, Ford AC. Derwa Y, et al. Aliment Pharmacol Ther. 2017 Aug;46(4):389-400. doi: 10.1111/apt.14203. Epub 2017 Jun 27. Aliment Pharmacol Ther. 2017. PMID: 28653751 Review. - Diet therapy for inflammatory bowel diseases: The established and the new.
Durchschein F, Petritsch W, Hammer HF. Durchschein F, et al. World J Gastroenterol. 2016 Feb 21;22(7):2179-94. doi: 10.3748/wjg.v22.i7.2179. World J Gastroenterol. 2016. PMID: 26900283 Free PMC article. Review.
Cited by
- Gut Microbiome Changes in Patients with Active Left-Sided Ulcerative Colitis after Fecal Microbiome Transplantation and Topical 5-aminosalicylic Acid Therapy.
Schierová D, Březina J, Mrázek J, Fliegerová KO, Kvasnová S, Bajer L, Drastich P. Schierová D, et al. Cells. 2020 Oct 13;9(10):2283. doi: 10.3390/cells9102283. Cells. 2020. PMID: 33066233 Free PMC article. Clinical Trial. - Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a Retrospective Cohort Study.
Dore MP, Rocchi C, Longo NP, Scanu AM, Vidili G, Padedda F, Pes GM. Dore MP, et al. Probiotics Antimicrob Proteins. 2020 Mar;12(1):152-159. doi: 10.1007/s12602-019-9517-0. Probiotics Antimicrob Proteins. 2020. PMID: 30685823 - Protective Effect of Probiotics Isolated from Traditional Fermented Tea Leaves (Miang) from Northern Thailand and Role of Synbiotics in Ameliorating Experimental Ulcerative Colitis in Mice.
Kangwan N, Kongkarnka S, Boonkerd N, Unban K, Shetty K, Khanongnuch C. Kangwan N, et al. Nutrients. 2022 Jan 5;14(1):227. doi: 10.3390/nu14010227. Nutrients. 2022. PMID: 35011101 Free PMC article. - Quality of Life in Inflammatory Bowel Diseases (IBDs) Patients after Surgery.
Di Candido F. Di Candido F. Rev Recent Clin Trials. 2022;17(4):227-239. doi: 10.2174/1574887117666220811143426. Rev Recent Clin Trials. 2022. PMID: 35959618 Review. - Prevention of radiotherapy induced enteropathy by probiotics (PREP): protocol for a double-blind randomized placebo-controlled trial.
Kim YJ, Yu J, Park SP, Lee SH, Kim YS. Kim YJ, et al. BMC Cancer. 2021 Sep 16;21(1):1032. doi: 10.1186/s12885-021-08757-w. BMC Cancer. 2021. PMID: 34530750 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical